pifithrin has been researched along with B16 Melanoma in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Li, J | 1 |
Sun, Y | 1 |
Yan, R | 1 |
Wu, X | 1 |
Zou, H | 1 |
Meng, Y | 1 |
Dabrowska-Iwanicka, A | 1 |
Olszewska, D | 1 |
Jalili, A | 1 |
Makowski, M | 1 |
Grzela, T | 1 |
Marczak, M | 1 |
Hoser, G | 1 |
Giermasz, A | 1 |
Golab, J | 1 |
Jakóbisiak, M | 1 |
2 other studies available for pifithrin and B16 Melanoma
Article | Year |
---|---|
Urea transporter B downregulates polyamines levels in melanoma B16 cells via p53 activation.
Topics: Acetylcysteine; Animals; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Down-Regul | 2022 |
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzothiazoles; Blotting, Western; Cell Div | 2002 |